About Index Trending news
Analyze
Pricing
Aisling Capital LLC

Aisling Capital LLC

Aisling Capital LLC

I work here Suggest edits
More info

Elsewhere

Also headquartered in New York

Verizon Verizon IBM IBM HBO HBO Kickstarter Kickstarter Wired Wired AOL AOL Tumblr Tumblr Goldman Sachs Goldman Sachs Time Warner Time Warner BuzzFeed BuzzFeed

Companies in the same industry

Finance Indonesia Finance Indonesia Tech Coast Angels Tech Coast Angels J.P. Morgan J.P. Morgan Propel(x) Propel(x) CapHorn Invest CapHorn Invest wikifolio.com wikifolio.com OCE OCE Aviva Innovation Aviva Innovation Fundnel Fundnel Southridge LLC Southridge LLC

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 34

Portfolio

Portfolio tracker
Add info

Investment profile

Target markets
Health Care Biotechnology Medical Devices

Activity

Past year's investments

- Aisling Capital participated in 5 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $264,000,000 (averaging $52,800,000 per round).

Latest rounds

- Menlo Therapeutics: Venture capital (Series C) ($50M)
- Earlens Corporation: Venture capital (Series C) ($73M)
- Promentis Pharmaceuticals: Venture capital (Series C) ($26M)

Main Co-investors

- OrbiMed Advisors
- Kearny Venture Partners
- Fidelity Biosciences

Syros Pharmaceuticals

Syros Pharmaceuticals

Biotechnology
Total funding
$123M in 3 rounds from 13 investors
By Aisling Capital
$40M Series C in Jan, 2016
ViewRay

ViewRay

Medical +3
Total funding
$280.8M in 13 rounds from 43 investors
By Aisling Capital
$26.7M Venture Capital in Jul, 2015
LENSAR, Inc.

LENSAR, Inc.

Medical Devices +1
Total funding
$110M in 4 rounds from 7 investors
By Aisling Capital
$60M Debt financing in Oct, 2013
Exit ALPHAEON, Nov 16, 2015
Zeltiq

Zeltiq

Medical Devices +1
Total funding
$70.4M in 3 rounds from 7 investors
By Aisling Capital
$25M Series D in Jun, 2010
Exit Allergan plc, Feb 13, 2017
Tria Beauty

Tria Beauty

E-Commerce
Total funding
$169.3M in 8 rounds from 23 investors
By Aisling Capital
$45.5M Private equity in Jul, 2013
Miramar Labs

Miramar Labs

Health Care +2
Total funding
$50.6M in 3 rounds from 8 investors
By Aisling Capital
$26M Series D in Oct, 2014
Roka Bioscience

Roka Bioscience

Biotechnology
Total funding
$67.5M in 2 rounds from 8 investors
By Aisling Capital
$47.5M Series D in Jan, 2012
Dermira, Inc.

Dermira, Inc.

Biotechnology
Total funding
$129.5M in 4 rounds from 16 investors
By Aisling Capital
$51M Series C in Aug, 2014
T2 Biosystems

T2 Biosystems

Health Care +2
Total funding
$123.5M in 6 rounds from 34 investors
By Aisling Capital
$40M Series E in Mar, 2013
Prolacta Bioscience

Prolacta Bioscience

Nutrition +1
Total funding
$63M in 4 rounds from 6 investors
By Aisling Capital
$35M Venture Capital in Dec, 2016
Earlens Corporation

Earlens Corporation

Medical +2
Total funding
$169M in 4 rounds from 14 investors
By Aisling Capital
$73M Series C in Jun, 2017
Versartis, Inc.

Versartis, Inc.

Health Care
Total funding
$119.5M in 5 rounds from 18 investors
By Aisling Capital
$55M Series E in Feb, 2014
Zavante Therapeutics, Inc.

Zavante Therapeutics, Inc.

Medical +2
Total funding
$65M in 3 rounds from 5 investors
By Aisling Capital
$45M Series A in Mar, 2016
Xanodyne Pharmaceuticals

Xanodyne Pharmaceuticals

Biotechnology +1
Total funding
$87.8M in 1 rounds from 7 investors
By Aisling Capital
$87.8M Series D in Oct, 2009
Cidara Therapeutics

Cidara Therapeutics

Health Care +2
Total funding
$100.9M in 4 rounds from 16 investors
By Aisling Capital
$42M Series B in Feb, 2015
Spirox, Inc.

Spirox, Inc.

Biotechnology
Total funding
$45M in 1 rounds from 5 investors
By Aisling Capital
$45M Series C in Mar, 2016
Powervision

Powervision

Hardware +1
Total funding
$10M in 1 rounds from 3 investors
By Aisling Capital
$10M Series D in Apr, 2016
F2G

F2G

Medical +2
Total funding
$60M in 1 rounds from 8 investors
By Aisling Capital
$60M Venture Capital in Jun, 2016
Promentis Pharmaceuticals

Promentis Pharmaceuticals

Medical +2
Total funding
$34.7M in 2 rounds from 4 investors
By Aisling Capital
$26M Series C in Mar, 2017
Biohaven Pharmaceuticals

Biohaven Pharmaceuticals

Biotechnology
Total funding
$100M in 2 rounds from 13 investors
By Aisling Capital
$80M Venture Capital in Nov, 2016
Menlo Therapeutics

Menlo Therapeutics

Biotechnology
Total funding
$50M in 1 rounds from 9 investors
By Aisling Capital
$50M Series C in Jul, 2017

Want to see the complete list?
Go Pro!